Leptin and adiponectin levels in obstructive sleep apnea phenotypes

Papers of special note have been highlighted: • of interest

References

• 1. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am. J. Physiol. Heart Circ. Physiol., 279(1), 234–237 (2000). • Reports that serum leptin levels in obstructive sleep apnea (OSA) patients were significantly higher than controls
  Google Scholar
• 2. Harsch IA, Konturek PC, Koebnick C et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur. Respir. J., 22(2), 251–257 (2003).
  Medline CASGoogle Scholar
• 3. Lam JC, Xu A, Tam S et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep, 31(12), 1721–1727 (2008).
  MedlineGoogle Scholar
• 4. Zhang XL, Yin KS, Wang H, Su S. Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration, 73(1), 73–77 (2006). • This study showed lower level of adiponectin in OSA
  MedlineGoogle Scholar
• 5. Al Mutairi S, Mojiminiyi OA, Al Alawi A, Al Rammah T, Abdella N. Study of leptin and adiponectin as disease markers in subjects with obstructive sleep apnea. Dis. Markers, 2014, 706314 (2014). • Evaluates the relationship between OSA severity and leptin and reported lower leptin levels in severe OSA similar to our results.
  MedlineGoogle Scholar
• 6. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med., 8(1), 12–17 (2007).
  Medline CASGoogle Scholar
• 7. Tokuda F, Sando Y, Matsui H, Koike H, Yokoyama T. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med., 47(21), 1843–1849 (2008). • Shows higher leptin levels in patients with apnea hypopnea index (AHI) >39/h compared with patients with AHI between 10 and 39. They also found a positive correlation with AHI.
  MedlineGoogle Scholar
• 8. Sanchez-de-la-Torre M, Mediano O, Barcelo A et al. The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath., 16(3), 649–656 (2012).
  MedlineGoogle Scholar
• 9. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 257(1), 79–83 (1999).
  Medline CASGoogle Scholar
• 10. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med., 165(5), 670–676 (2002).
  MedlineGoogle Scholar
• 11. Arnardottir ES, Maislin G, Jackson N et al. The role of obesity, different fat compartments and sleep apnea severity in circulating leptin levels: the Icelandic Sleep Apnea Cohort study. Int. J. Obes., 37(6), 835–842 (2013).
  CASGoogle Scholar
• 12. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest, 122(3), 829–839 (2002).
  MedlineGoogle Scholar
• 13. Barcelo A, Barbe F, Llompart E et al. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am. J. Respir. Crit. Care Med., 171(2), 183–187 (2005).
  MedlineGoogle Scholar
• 14. Makino S, Handa H, Suzukawa K et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin. Endocrinol. (Oxf.), 64(1), 12–19 (2006).
  Medline CASGoogle Scholar
• 15. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest., 127(3), 716–721 (2005).
  MedlineGoogle Scholar
• 16. Ursavas A, Ilcol YO, Nalci N, Karadag M, Ege E. Ghrelin, leptin, adiponectin, and resistin levels in sleep apnea syndrome: role of obesity. Ann. Thorac. Med., 5(3), 161–165 (2010).
  Medline CASGoogle Scholar
• 17. Wysocka E, Cofta S, Dziegielewska S, Gozdzik J, Torlinski L, Batura-Gabryel H. Adipocytokines in sleep apnea syndrome. Eur. J. Med. Res., 14(4), 255–258 (2009).
  MedlineGoogle Scholar
• 18. Hargens TA, Guill SG, Kaleth AS et al. Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath, 17(1), 403–409 (2013).
  MedlineGoogle Scholar
• 19. Kosacka M, Korzeniewska A, Jankowska R. The evaluation of body composition, adiponectin, C-reactive protein and cholesterol levels in patients with obstructive sleep apnea syndrome. Adv. Clin. Exp. Med., 22(6), 817–824 (2013).
  MedlineGoogle Scholar
• 20. Hotta K, Funahashi T, Arita Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in Type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol., 20(6), 1595–1599 (2000).
  Medline CASGoogle Scholar
• 21. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler. Thromb. Vasc. Biol., 24(1), 29–33 (2004).
  Medline CASGoogle Scholar
• 22. Wolk R, Shamsuzzaman AS, Somers VK. Obesity, sleep apnea, and hypertension. Hypertension, 42(6), 1067–1074 (2003).
  Medline CASGoogle Scholar
• 23. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur. Heart J., 25(9), 735–741 (2004).
  MedlineGoogle Scholar
• 24. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest, 118(3),580–586 (2000).
  Medline CASGoogle Scholar
• 25. Medical Section of the American Lung Association. American Thoracic society Standardization of spirometry, 1994 update. Am. J. Respir. Crit. Care Med., 152(3), 1107–1136 (1995).
  MedlineGoogle Scholar
• 26. Rudski LG, Lai WW, Afilalo J et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr., 23(7), 685–713 (2010).
  MedlineGoogle Scholar
• 27. Berry RB, Budhiraja R, Gottlieb DJ et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J. Clin. Sleep Med., 8(5), 597–619 (2012).
  MedlineGoogle Scholar
• 28. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd ed: Diagnostic and coding manual American Academy of Sleep Medicine, IL, USA (2005).
  Google Scholar
• 29. Masserini B, Morpurgo PS, Donadio F et al. Reduced levels of adiponectin in sleep apnea syndrome. J. Endocrinol. Invest., 29(8), 700–705 (2006).
  Medline CASGoogle Scholar
• 30. Wolk R, Svatikova A, Nelson CA et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes. Res., 13(1), 186–190 (2005).
  Medline CASGoogle Scholar
• 31. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal weight and obese women. Eur. J. Endocrinol., 147(2), 173–180 (2002).
  Medline CASGoogle Scholar
• 32. de Lima AM, Franco CM, de Castro CM, Bezerra Ade A, AtaídeLJr, Halpern A. Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration, 79(5), 370–376 (2010).
  MedlineGoogle Scholar
• 33. Ozturk L, Unal M, Tamer L, Celikoglu F. The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch. Otolaryngol. Head Neck Surg., 129(5), 538–540 (2003). • Shows a positive correlation between leptin level and OSA severity regardless of BMI and age.
  MedlineGoogle Scholar
• 34. Shimura R, Tatsumi K, Nakamura A et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest, 127(2), 543–549 (2005). • Reports that leptin was the only predictor of hypercapnia.
  Medline CASGoogle Scholar
• 35. Campo A, Frühbeck G, Zulueta JJ et al. Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. Eur. Respir. J., 30(2), 223–231 (2007).
  Medline CASGoogle Scholar
• 36. Makinodan K, Yoshikawa M, Fukuoka A et al. Effect of serum leptin levels on hypercapnic ventilatory response in obstructive sleep apnea. Respiration, 75(3), 257–264 (2008).
  Medline CASGoogle Scholar
• 37. Phipps PR, Starritt E, Caterson I, Grunstein RR. Association of serum leptin with hypoventilation in human obesity. Thorax, 57(1), 75–76 (2002).
  Medline CASGoogle Scholar
• 38. Lindsay RS, Funahashi T, Hanson RL et al. Adiponectin and development of Type 2 diabetes in the Pima Indian population. Lancet, 360(9326), 57–58 (2002).
  Medline CASGoogle Scholar
• 39. Thomas T, Burguera B, Melton LJ et al. Relationshipof serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism, 49(10), 1278–1284 (2000).
  Medline CASGoogle Scholar
• 40. Kapsimalis F, Varouchakis G, Manousaki A et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung, 186(4), 209–217 (2008).
  Medline CASGoogle Scholar